Why do you give Kayexalate?
Table of Contents
Why do you give Kayexalate?
This medication is used to treat a high level of potassium in your blood. Too much potassium in your blood can sometimes cause heart rhythm problems. Sodium polystyrene sulfonate works by helping your body get rid of extra potassium.
When should Kayexalate be given?
ORAL DOSING When taken by mouth, KAYEXALATE should be taken at least 3 hours before or 3 hours after other oral medications. For patients with gastroparesis (a condition preventing your stomach from emptying properly), a 6-hour separation should be considered.
Is Kayexalate a contraindication?
KAYEXALATE is contraindicated in the following conditions: patients with hypokalemia, patients with a history of hypersensitivity to polystyrene sulfonate resins, obstructive bowel disease, neonates with reduced gut motility (postoperatively or drug induced) and oral administration in neonates (see PRECAUTIONS).
Why is Kayexalate given for hyperkalemia?
Kayexalate (Sodium polystyerene sulfonate) is a cation-exchange resin that was approved in 1958 as a treatment for hyperkalemia by helping to exchange sodium for potassium in the colon and thus excreting potassium from the body. This drug has been a standard part of treatment of hyperkalemia for decades.
Can Kayexalate cause hypokalemia?
Hypokalemia: Serious potassium deficiency can occur from therapy with KAYEXALATE. The effect must be carefully controlled by frequent serum potassium determinations within each 24 hour period.
What is the action of Kayexalate?
Kayexalate binds itself to potassium in your digestive tract. This helps prevent your body from absorbing too much potassium. Kayexalate is used to treat high levels of potassium in the blood, also called hyperkalemia.
Can you give Kayexalate with other medications?
Clinicians should advise patients who take sodium polystyrene sulfonate (Kayexalate, Concordia Pharmaceuticals) for hyperkalemia to not take any other oral drugs 3 hours before or after, the US Food and Drug Administration (FDA) announced today.
